Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents

Journal of Biological Chemistry

Volumn 277, Issue 51, 2002, Pages 49374-49382

  Mercatante, Danielle R ^a   Mohler, James L ^a   Kole, Ryszard ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; GENES; ISOTOPES; MODULATION; OLIGOMERS; RADIATION; RNA; TUMORS;

APOPTOSIS;

BIOCHEMISTRY;

2' O METHYL OLIGORIBONUCLEOSIDE PHOSPHOROTHIOATE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BCL XS; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL LINE; CELL STRAIN MCF 7; DOWN REGULATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SPECIFICITY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOXORUBICIN; FEMALE; HUMANS; MALE; MODELS, GENETIC; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION-SENSITIZING AGENTS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASES; RNA; RNA SPLICING; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0345829926     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M209236200     Document Type: Article

References (66)

1. Han, J. S., Nunez, G., Wicha, M. S., and Clarke, M. F. (1998) Springer Semin. Immunopathol. 19, 279-288
2. Lowe, S. W., and Lin, A. W. (2000) Carcinogenesis 21, 485-495
3. Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C. M., and Murphy, K. C. (1996) J. Clin. Oncol. 14, 1756-1764
4. Savarese, D. M., Halabi, S., Hars, V., Akerley, W. L., Taplin, M. E., Godley, P. A., Hussain, A., Small, E. J., and Vogelzang, N. J. (2001) J. Clin. Oncol. 19, 2509-2516
5. Kantoff, P. W., Halabi, S., Conaway, M., Picus, J., Kirshner, J., Hars, V., Trump, D., Winer, E. P., and Vogelzang, N. J. (1999) J. Clin. Oncol. 17, 2506-2513
6. Amundson, S. A., Myers, T. G., Scudiero, D., Kitada, S., Reed, J. C., and Fornace, A. J., Jr. (2000) Cancer Res. 60, 6101-6110
7. Sellers, W. R., and Fisher, D. E. (1999) J. Clin. Invest. 104, 1655-1661
8. Reed, J. C. (1999) J. Clin. Oncol. 17, 2941-2953
9. Olopade, O. I., Adeyanju, M. O., Safa, A. R., Hagos, F., Mick, R., Thompson, C. B., and Recant, W. M. (1997) Cancer J. Sci. Am. 3, 230-237
10. Lebedeva, I., Rando, R., Ojwang, J., Cossum, P., and Stein, C. A. (2000) Cancer Res. 60, 6052-6060
11. Minn, A. J., Rudin, C. M., Boise, L. H., and Thompson, C. B. (1995) Blood 86, 1903-1910
12. Nita, M. E., Ono-Nita, S. K., Tsuno, N., Tominaga, O., Takenoue, T., Sunami, E., Kitayama, J., Nakamura, Y., and Nagawa, H. (2000) Jpn. J. Cancer Res. 91, 825-832
13. Broome, H. E., Yu, A. L., Diccianni, M., Camitta, B. M., Monia, B. P., and Dean, N. M. (2002) Leuk. Res. 26, 311-316
14. Boise, L. H., Gonzalez-Garcia, M., Posterna, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. (1993) Cell 74, 597-608
15. Clarke, M. F., Apel, I. J., Benedict, M. A., Eipers, P. G., Sumantran, V., Gonzalez-Garcia, M., Doedens, M., Fukunaga, N., Davidson, B., Dick, J. E., and et al. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11024-11028
16. Ealovega, M. W., McGinnis, P. K, Sumantran, V. N., Clarke, M. F., and Wicha, M. S. (1996) Cancer Res. 56, 1965-1969
17. Ohi, Y., Kim, R., and Toge, T. (2000) Int. J. Oncol. 16, 959-969
18. Taylor, J. K, Zhang, Q. Q., Monia, B. P., Marcusson, E. G., and Dean, N. M. (1999) Oncogene 18, 4495-4504
19. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. (1995) Cancer Res. 55, 2507-2510
20. Kim, R., Ohi, Y., Inoue, H., and Toge, T. (1999) Int. J. Oncol. 15, 751-756
21. Minn, A. J., Boise, L. H., and Thompson, C. B. (1996) J. Biol. Chem. 271, 6306-6312
22. Fridman, J. S., Parsels, J., Rehemtulla, A., and Maybaum, J. (2001) J. Biol. Chem. 276, 4205-4210
23. Mercatante, D. R., Bortner, C. D., Cidlowski, J. A., and Kole, R. (2001) J. Biol. Chem. 276, 16411-16417
24. Taylor, J. K., Zhang, Q. Q., Wyatt, J. R., and Dean, N. M. (1999) Nat. Biotechnol. 17, 1097-1100
25. Nieves-Neira, W., and Pommier, Y. (1999) Int. J. Cancer 82, 396-404
26. Cattaneo-Pangrazzi, R. M., Schott, H., Wunderli-Allenspach, H., Rothen-Rutishauser, B., Guenthert, M., and Schwendener, R. A. (2000) J. Cancer Res. Clin. Oncol. 126, 247-256
27. Carroll, A. G., Voeller, H. J., Sugars, L., and Gelmann, E. P. (1993) Prostate 23, 123-134
28. Kalkhoven, E., Roelen, B. A., de Winter, J, P., Mummery, C. L., van den Eijnden-van Raaij, A. J., van der Saag, P. T., and van der Burg, B. (1995) Cell Growth & Differ, 6, 1151-1161
29. Shao, Z. M., Shen, Z. Z., Fontana, J. A., and Barsky, S. H. (2000) Anticancer Res. 20, 2409-2416
30. Wei, Q., and Adelstein, R. S. (2002) Mol. Biol. Cell 13, 683-697
31. Sierakowska, H., Sambade, M. J., Schumperli, D., and Kole, R. (1999) RNA 5, 369-377
32. Strasberg Rieber, M., Zangemeister-Wittke, U., and Rieber, M. (2001) Clin. Cancer Res. 7, 1446-1451
33. Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., and Grant, S. (1999) Oncogene 18, 7016-7025
34. Lee, J. U., Hosotani, R., Wada, M., Doi, R., Kosiba, T., Fujimoto, K., Miyamoto, Y., Tsuji, S., Nakajima, S., Nishimura, Y., and Imamura, M. (1999) Eur. J. Cancer 35, 1374-1380
35. Zhan, Q, Alamo, I., Yu, K., Boise, L. H., Cherney, B., Tosato, G., O'Connor, P. M., and Fornace, A. J., Jr. (1996) Oncogene 13, 2287-2293
36. Sakakura, C., Sweeney, E. A., Shirahama, T., Igarashi, Y., Hakomori, S., Nakatani, H., Tsujimoto, H., Imanishi, T., Ohgaki, M., Ohyama, T., Yamazaki, J., Hagiwara, A., Yamaguchi, T., Sawai, K., and Takahashi, T. (1996) Int. J. Cancer 67, 101-105
37. Ogretmen, B., and Safa, A. R. (1996) Int. J. Cancer 67, 608-614
38. Benderra, Z., Trussardi, A., Morjani, H., Villa, A. M., Doglia, S. M., and Manfait, M. (2000) E. J. Cancer 36, 428-434
39. Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. (1987) Cancer Res. 47, 5141-5148
40. Schneider, E., Yamazaki, H., Sinha, B. K., and Cowan, K. H., (1995) Br. J. Cancer 71, 738-743
41. Schneider, E., Horton, J. K., Yang, C. H., Nakagawa, M., and Cowan, K. H. (1994) Cancer Res. 54, 152-158
42. Leech, S. H., Olie, R. A., Gautschi, O., Simoes-Wust, A. P., Tschopp, S., Haner, R., Hall, J., Stahel, R. A., and Zangemeister-Wittke, U. (2000) Int. J. Cancer 86, 570-576
43. Xu, Z., Friess, H., Solioz, M., Aebi, S., Korc, M., Kleeff, J., and Buchler, M. W. (2001) Int. J. Cancer 94, 268-274
44. Fennell, D. A., Corbo, M. V., Dean, N, M., Monia, B. P., and Cotter, F. E. (2001) Br. J. Haematol. 112, 706-713
45. Gautschi, O., Tschopp, S., Olie, R. A., Leech, S. H., Simoes-Wust, A. P., Ziegler, A., Baumann, B., Odermatt, B., Hall, J., Stahel, R. A., and Zangemeister-Wittke, U. (2001) J. Natl. Cancer Inst. 93, 463-471
46. Olie, R. A., and Zangemeister-Wittke, U. (2001) Drug Resist. Update 4, 9-15
47. Miyake, H., Hara, I., Kamidono, S., and Gleave, M. E. (2001) Int. J. Urol. 8, 337-349
48. Vilenchik, M., Raffo, A. J., Benimetskaya, L., Shames, D., and Stein, C. A. (2002) Cancer Res. 62, 2175-2183
49. Razandi, M., Pedram, A., and Levin, E. R. (2000) Mol. Endocrinol. 14, 1434-1447
50. Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., and Reed, J. C. (1996) Am. J. Pathol. 148, 1567-1576
51. Tsushima, H., Urata, Y., Miyazaki, Y., Fuchigami, K., Kuriyama, K., Kondo, T., and Tomonaga, M. (1997) Cell Growth & Differ. 8, 1317-1328
52. Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., and Seckl, M. J. (2002) J. Biol. Chem. 28, 28
53. Bennett, C. F. (1999) Exp. Opin. Invest. Drugs 8, 237-253
54. Dorr, F. A., Glover, J, G., and Kwoh, T. J. (2001) in Antisense Drug Technology: Principles, strategies, and applications (Crooke, S. T., ed), pp. 269-290, Marcel Dekker, Inc., New York
55. Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Nunez, G., and Castle, V. P. (1995) Cancer Res. 55, 2576-2582
56. Yang, C. C., Hsu, C. P., and Yang, S. D. (2000) Clin. Cancer Res, 6, 1024-1030
57. Mesner, P., Budihardjo, I., and Kaufmann, S. (1997) Adv. Pharmacol. 41, 461-499
58. Katzung, B. G. (1998) Basic and Clinical Pharmacology, 7th Ed., pp. 881-915, Appleton and Lange, Stamford, CT
59. Ghoshal, K., and Jacob, S. T. (1997) Biochem. Pharmacol. 53, 1569-1575
60. Blagosklonny, M. V. (2001) Leukemia 15, 869-874
61. Peters, G. J., van der Wilt, C. L., van Moorsel, C. J., Kroep, J. R., Bergman, A. M., and Ackland, S. P. (2000) Pharmacol. Ther. 87, 227-253
62. Kano, Y., Akutsu, M., Tsunoda, S., Suzuki, K., and Yazawa, Y. (1996) Cancer Chemother. Pharmacol. 37, 525-530
63. Mercatante, D. R., and Kole, R. (2002) Biochim. Biophys. Acta 1587, 126-132
64. Fisher, A, A., Ye, D., Sergueev, D. S., Fisher, M. H., Shaw, B. R., and Juliano, R. L. (2002) J. Biol. Chem, 277, 22980-22984
65. Cho, Y. S., Kim, M. K., Cheadle, C., Neary, C., Becker, K. G., and Cho-Chung, Y. S. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 9819-9823
66. Sazani, P., Kang, S. H., Maier, M. A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., and Kole, R. (2001) Nucleic Acids Res. 29, 3965-3974